Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
InflaRx N.V. has appointed Gabriela Alperovich, MD, PhD, as SVP & Global Head of Clinical Development. This role is effective October 1, 2026, and she will oversee programs including izicopan in AAV and other renal indications.
InflaRx N.V. has appointed Gabriela Alperovich, MD, PhD, as its new Senior Vice President & Global Head of Clinical Development. Alperovich will lead the company's clinical development efforts for its anti-inflammatory therapeutics targeting the complement system.